Studies have shown significantly elevated levels of ACE2 autoantibodies (ACE2-AA) in PD patients, which are correlated with various inflammatory factors and metabolites, suggesting a potential role of ACE2 in PD [82]. The gene discussed is ACE2; the disease is Parkinson disease.